Liver Cancer Breakthrough News
|
|
July 23, 2008
Sorafenib Extends
Advanced Liver Cancer Survival |
|
|
By Crystal Phend, Staff Writer, MedPage Today
NEW YORK, July 23
-- Sorafenib (Nexavar), an oral kinase inhibitor,
modestly extends survival in advanced liver cancer,
researchers found.
<READ
MORE> |
|
|
|
|
Apr 8, 2008
Combination Therapy Improves Hepatocellular
Carcinoma Survival |
|
|
By Crystal Phend, Staff Writer, MedPage Today
JINAN, China,
April 8 -- For large hepatocellular carcinoma
tumors, transarterial chemoembolization plus
radiofrequency ablation improves survival better
than either alone, according to researchers here.
<READ
MORE> |
|
|
|
|
Jan
28, 2008
ASCO GI: HCV Infection
Does Not Blunt Sorafenib Response in Liver Cancer |
|
|
By Peggy Peck, Executive Editor, MedPage Today
ORLANDO, Jan. 28
-- Infection with hepatitis C did not affect
response to sorafenib (Nexavar) used to treat liver
cancer, researchers said here. <READ
MORE> |
|
|
|
|
Oct
26, 2007
AACR-NCI-EORTC: Sunitinib Shows Early Promise in
Liver Cancer |
|
|
By Crystal Phend, Staff Writer, MedPage Today
SAN FRANCISCO, Oct. 26
-- Sunitinib (Sutent) appears to be effective in
advanced hepatocellular cancer, according to a small
study. <READ
MORE> |
|
|
|
|
|
|
